基本资料 投资组合 财务数据 基金公告
汇添富创新医药混合C(024344) |
净值：
1.7148
|
日增长率：
-0.71%
|
累计净值：1.7148 | 2026-05-06 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| 06990 | 科伦博泰生物 | 2,899,200.00 | 1,177,530,374.40 | 9.71 |
| 01801 | 信达生物 | 15,679,500.00 | 1,175,373,813.17 | 9.69 |
| 600276 | 恒瑞医药 | 20,950,570.00 | 1,156,890,475.40 | 9.54 |
| 01530 | 三生制药 | 56,792,000.00 | 1,135,271,398.50 | 9.36 |
| 01093 | 石药集团 | 127,114,000.00 | 1,021,341,287.33 | 8.42 |
| 002653 | 海思科 | 17,053,464.00 | 925,662,025.92 | 7.63 |
| 688506 | 百利天恒 | 2,927,166.00 | 813,752,148.00 | 6.71 |
| 688266 | 泽璟制药 | 6,563,074.00 | 648,431,711.20 | 5.35 |
| 002294 | 信立泰 | 7,937,388.00 | 486,641,258.28 | 4.01 |
| 688331 | 荣昌生物 | 1,836,036.00 | 236,426,355.72 | 1.95 |
| 09995 | 荣昌生物 | 1,381,000.00 | 116,814,108.41 | 0.96 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-03-31 | 89.74 | - | 10.97 | 12,126,186,595.65 |
| 2025-12-31 | 90.51 | - | 10.04 | 11,881,367,144.28 |
| 2025-09-30 | 93.82 | - | 6.52 | 13,473,977,322.85 |
| 2025-06-30 | 92.61 | 0.01 | 9.10 | 9,275,735,452.13 |
微信公众号
证券之星APP
